Age-related changes in nitric oxide activity, cyclic GMP, and TBARS levels in platelets and erythrocytes reflect the oxidative status in central nervous system

Age

Volumn 35, Issue 2, 2013, Pages 331-342

  Kawamoto, Elisa Mitiko ^a,b   Vasconcelos, Andrea Rodrigues ^a   Degaspari, Sabrina ^a   Böhmer, Ana Elisa ^a   Scavone, Cristoforo ^a   Marcourakis, Tania ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aging; Cyclic GMP; Nitric oxide; Peripheral markers; TBARS

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; RAT; SIGNAL TRANSDUCTION; THROMBOCYTE;

AGING; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BLOOD PLATELETS; CYCLIC GMP; ERYTHROCYTES; FRONTAL LOBE; HIPPOCAMPUS; MALE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84880572941     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-011-9365-7     Document Type: Article

References (53)

1. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Peterson RC, Kokmen E (1995) No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease. Mov Disord 10:566-573
2. Baba A, Yoshikawa T, Mitamura H, Ogawa S (1999) Erythrocyte Nap, Kp-ATPase activity in patients with congestive heart failure. Int J Cardiol 69:117-125
3. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide and peroxynitrite: the good, the bad and ugly. Am J Physiol 271:C1424-C1437
4. Blanco S, Molina FJ, Castro L, Del Moral ML, Hernandez R, Jimenez A, Rus A, Martinez-Lara E, Siles E, Peinado MA (2010) Study of the nitric oxide system in the rat cerebellum during aging. BMC Neurosci 11(78 11):78-91
5. Bolanos JP, Almeida A, Stewart V, Peuchen S, Land JM, Clark JB, Heales SJ (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 68:2227-2240
6. Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B, el Mlili N, Boix J, Agustí A, Felipo V (2010) Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications. Metab Brain Dis 1:69-80
7. Chalimoniuk M, Strosznajder JB (1998) Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide. Mol Chem Neuropathol 35(1-3):77-95
8. Chiavegatto S, Scavone C, Canteras NS (1998) Nitric oxide synthase activity in the dorsal periaqueductal gray of rats expressing innate fear response. NeuroReport 9:571-576
9. Dégenètais E, Thierry A-M, Glowinski J, Gioanni Y (2003) Synaptic influence of hippocampus on pyramidal cells of the rat prefrontal cortex: an in vivo intracellular recording study. Cereb Cortex 13(7):782-792
10. Domek-Łopacińska KU, Strosznajder JB (2010) Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease. Mol Neurobiol 41(2-3):129-137
11. Férino F, Thierry AM, Glowinski J (1987) Anatomical and electrophysiological evidence for a direct projection from Ammon's horn to the medial prefrontal cortex in the rat. Exp Brain Res 65:421-426
12. Floyd RA (1999) Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic Biol Med 26:1346-1355
13. Förstermann U, Kleinert H (1995) Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol 352:351-364
14. Freitas JJ, Pompéia C, Miyasaka CK, Curi R (2001) Walker-256 tumor growth causes oxidative stress in rat brain. J Neurochem 77(2):655-663
15. Fuster JM (1991) The prefrontal cortex and its relation to behavior. Prog Brain Res 87:201-211
16. Garthwaite J (1991) Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci 14(2):60-67
17. Garthwaite J, Boulton CL (1995) Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57:683-706
18. Gloor SM (1997) Relevance of Na, K-ATPase to local extracellular potassium homeostasis and modulation of synaptic transmission. FEBS Lett 412:1-4
19. Halliwell B, Gutteridge JMC (2007) Free radical in Biology and Medicine., vol 4th. Free radical in Biology and Medicine. Oxford University Press, New York
20. 2+-ATPase activity in the brain plasma membrane of rats with increasing age: involvement of brain calcium accumulation. Int J Mol Med 7(4):407-411
21. Harman D (1981) The aging process. Proc Natl Acad Sci U S A 78(11):7124-7128
22. Harman D (1995) Free radical theory of aging: Alzheimer's disease pathogenesis. Age 18:97-119
23. Harman D (1998) Aging: phenomena and theories. Ann N Y Acad Sci 854:1-7
24. Kawamoto EM, Munhoz CD, Glezer I, Bahia VS, Caramelli P, Nitrini R, Gorjão R, Curi R, Scavone C, Marcourakis T (2005) Oxidative stress in platelets and erythrocytes in aging and Alzheimer's disease. Neurobiol Aging 26:857-864
25. Kawamoto EM, Munhoz CD, Lepsch LB, De Sá Lima L, Markus RP, Marcourakis T, Scavone C (2007) Age-related changes in cerebellar Phosphatase-1 and Na,K-ATPase activities. Neurobiol Aging 9:1149-1159, 2007. Neurobiology of Aging 9:1149-1159
26. Kim WK, Ko KH (1998) Potenciation of N-methyl-d-aspartate-mediated neurotoxicity by immunostimulated murine microglia. J Neurosci Res 54:17-26
27. Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298:249-258
28. Koutsilieri E, Scheller C, Grünblatt E, Nara K, Li J, Riederer P (2002) Free radicals in Parkinson's disease. J Neurol 249 249(Suppl 2):II/1-II/5
29. Laroche S, Jay TM, Thierry AM (1990) Long-term potentiation in the prefrontal cortex following stimulation of the hippocampal CA1/subicular region. Neurosci Lett 114:184-190
30. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HSV, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632
31. Mamelak M (2007) Alzheimer's disease, oxidative stress and gammahydroxybutyrate. Neurobiol Aging 28:1340-1360
32. Marcourakis T, Bahia VS, Kawamoto EM, Munhoz CD, Gorjão R, Artes R, Kok F, Caramelli P, Nitrini R, Curi R, Scavone C (2008) Apolipoprotein E genotype is related to nitric oxide production in platelets. Cell Biochem Funct 26(8):852-858. doi: 10.1002/cbf.1516
33. McCann SM, Licinio J, Wong M-L, Yu WH, Karanth S, Rettorri V (1998) The nitric oxide hypothesis of aging. Exp Gerontol 7(8):813-826
34. Mckee M, Scavone C, Nathanson JA (1994) Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci U S A 91(25):12056-12060
35. Montoliu C, Rodrigo R, Monfort P, Llansola M, Cauli O, Boix J, Elmlili N, Agusti A, Felipo V (2010) Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications. Metab Brain Dis 25(1):39-48
36. Motulsky H (ed) (1995) Intuitive biostatistics. Oxford University Press, New York
37. Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417-2423
38. Puri SK, Volicer L (1981) Age-related changes of cyclic nucleotide levels in rat brain regions. Mech Ageing Dev 15:239-242
39. Sapolsky RM (1992) Stress, the aging brain, and the mechanism of neuron death. MIT Press, Cambridge
40. Scavone C, Munhoz CD, Kawamoto EM, Glezer I, de Sá LL, Marcourakis T, Markus RP (2005) Age-related changes in cyclic GMP and PKG-stimulated cerebellar Na, K-ATPase activity. Neurobiol Aging 26(6):907-916
41. Schmidt MJ, Thornberry JF (1978) Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged rats. Brain Res 139:169-177
42. Siles E, Martinez-Lara E, Canuelo A, Sanchez M, Hernandez R, Lopez-Ramos JC, Del Moral ML, Esteban FJ, Blanco S, Pedrosa JA, Rodrigo J, Peinado MA (2002) Age related changes of the nitric oxide system in the rat brain. Brain Res 956:385-392
43. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 88:10540-10543
44. Steiner AL, Parker CW, Kipnis DM (1972) Radioimmunoassay for cyclic nucleotides. J Biol Chem 247:1106
45. Swanson LW (1981) A direct projection from Ammon's horn to prefrontal cortex in the rat. Brain Res 217:150-154
46. Swerdlow RH (2007) Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiol Aging 28:1465-1480
47. +-ATPase. Brain Res 506:46-52
48. Teunissen CE, Lütjohann D, von Bergmann K, Verhey F, Vreeling F, Wauters A, Bosmans E, Bosma H, van Boxtel MP, Maes M, Delanghe J, Blom HJ, Verbeek MM, Rieckmann P, De Bruijn C, Steinbusch HW, de Vente J (2003) Combination of serum markers related to several mechanisms in Alzheimer's disease. Neurobiol Aging 24:893-902
49. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84
50. van der Staay FJ, Rutten K, Barfacker L, Devry J, Erb C, Hea H (2008) The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents. Neuropharmacology 55:908-918
51. Wink DA, Cook JA, Pacelli REA (1996) The effects of various nitric oxide-donor agents on hydrogen peroxide toxicity: a direct correlation between nitric oxide formation and protection. Arch Biochem Biophys 331:241-248
52. Xie Z, Jack-Hays M, Wang Y, Periyasamy SM, Blanco G, Huang WH, Askari A (1995) Different oxidant sensitivities of the alpha 1 and alpha 2 isoforms of Na/K-ATPase expressed in baculovirus-infected insect cells. Biochem Biophys Res Commun 207:155-159
53. Yu BP (1996) Aging and oxidative stress: modulation by dietary restriction. Free Radic Biol Med 21:651-668